The outcome and safety of re-challenge Lutetium-177 PSMA (177Lu-PSMA) therapy with Low-Dose Docetaxel as a Radiosensitizer—a promising combination in metastatic castrate-resistant prostate cancer (mCRPC) : a case report

The outcome and safety of re-challenge Lutetium-177 PSMA (177Lu-PSMA) therapy with Low-Dose Docetaxel as a Radiosensitizer—a promising combination in metastatic castrate-resistant prostate cancer (mCRPC) : a case report

Maharaj, Masha; Heslop, Lucille; Govender, Trisha; Korowlay, Nisaar; Singh, Aviral; Choudhary, Partha; Sathekge, Mike Machaba
URI: http://hdl.handle.net/2263/83831
Date: 2021-06

Abstract:

Please read abstract in the article.

Show full item record

Files in this item

Icon
Name: Maharaj_Outcome_2 ...
Size: 246.2Kb
Format: PDF
Description: Postprint Article
View/Open

This item appears in the following Collection(s)